CClinicalTrials.gg
Sign In
RecruitingNCT04329234KorHF-IIIUpdated Apr 1, 2020

Korean Heart Failure Registry III

An observational study in Acute Heart Failure, sponsored by Seoul National University Bundang Hospital. Recruiting at 1 site in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-01.

Sponsored by Seoul National University Bundang Hospital · Observational

From the registry’s dates

  • Started Oct 2018; still recruiting 8 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years and older
Sex
All
01

Study summary

KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea.

The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.

02

Conditions studied

  • Acute Heart Failure

Browse trials for

03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Seoul National University Bundang Hospital is the lead sponsor of 368 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with acute heart failure

All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4

Inclusion criteria

Inclusion Criteria:

  1. Symptoms of heart failure
  2. Signs of heart failure
  3. Lung congestion in Chest-x-ray
  4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels

Exclusion criteria

Exclusion Criteria:

  1. Patients younger than 18 years old
  2. Patients who do no consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • acute heart failure

    Patients with acute heart failure

06

What researchers measure

Primary outcomes

  1. In-hospital mortality

    In-hospital mortality

    Time frame: 5 years

  2. Post-discharge mortality

    Post-discharge mortality

    Time frame: 5 years

  3. Post-discharge re-hospitalization

    Post-discharge re-hospitalization

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
  • Seoul National University Bundang Hospital
    Seongnam, 463707, Korea, Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04329234
Lead sponsor
Seoul National University Bundang Hospital
Collaborators
Korean Society of Heart Failure
Responsible party
Dong-Ju Choi (Professor, Seoul National University Bundang Hospital) — Principal investigator
First posted
Apr 1, 2020
Start date
Oct 1, 2018
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 1, 2020

Study contacts

Dong-Ju Choi, MD, PhD
Contact
djchoi@snubh.org
82317877007
Jin Joo Park, MD, PhD
Contact
jinjooparkmd@gmail.com
82317877074

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Heart Failure→

Other studies from this sponsor

Seoul National University Bundang Hospital

Start the discussion